ONDA bodyESTIQ: contouring that spares the surface.
Microwave “Coolwaves” energy that targets subcutaneous fat, cellulite, and laxity — the manufacturer reports over 80% of energy absorbed by subcutaneous fat. Backed by 17 peer-reviewed studies, for licensed providers and practice owners.
- Modality
- Coolwaves 2.45 GHz microwave with sapphire-crystal contact cooling
- Manufacturer
- DEKA, sold in the US as bodyESTIQ. Eventide is a United States distributor, not the manufacturer.
- Regulatory
- ONDA is CE-marked; no US FDA clearance is claimed here. Treatments listed describe how licensed providers use the platform, not cleared indications.
- What it costs
- Quoted, not listed: configuration and the manufacturer's current launch programs both move the number.
A body line that books as a package — under a European marking
The argument for this platform is a protocol you can staff, price and repeat: defined quadrants, a fixed session count, and no downtime after. The argument to settle first is the regulatory one, because the marking behind it is European and the room you would put it in is not.
three modes on one console — fat, cellulite and laxity, all on the same body menu.
Practices that want a schedulable body menu
- You want localized fat, cellulite and laxity on one console rather than three.
- You want a protocol staff can be taught: 15×15 cm quadrants at roughly 15–20 minutes each, across more than ten mapped body areas.
- You sell courses rather than one-offs — treatment typically runs 3–4 sessions spaced 3–4 weeks apart.
- You want the appointment to cost the patient no downtime afterward.
Where the marking and the numbers stop
- ONDA is CE-marked; no US FDA clearance is claimed here. A CE mark is a European conformity marking and it is not a United States authorisation for any indication.
- Before you advertise anything, confirm the current US regulatory status and permitted marketing language with the manufacturer. That is a step, not a formality.
- The 80%+ absorption figure and the 55–60 °C deep-heating range are manufacturer-reported, not measured independently here.
- The literature is a bibliography of the underlying technology. We do not reproduce effect sizes, and nothing on this page claims a result for any patient.
- A quadrant protocol prices by area: a large abdomen is several quadrants, and room time scales with the map rather than with the patient.
What it offers in return is a category almost nobody else is in — 2.45 GHz microwave on a quadrant protocol — with a CE mark, a published bibliography, and a manufacturer you can put the regulatory question to directly before you advertise a word.
Four questions worth asking us
- What is the current US regulatory status, and what language may I use in my own marketing?
- Which launch programs are actually available at the time I quote — training, marketing kits, referral placement?
- What is the current warranty term, and what does service cost after it?
- How many quadrants does my typical patient need, and what does that do to room time?
An emitter, a cooling system, and a map of the body
ONDA uses 2.45 GHz Coolwaves® — microwave energy, not radiofrequency. The distinction is not marketing: it changes which tissue absorbs the energy. The platform is that emitter, the cooling that protects the surface while it works, and the quadrant protocol that turns both into something a clinic can schedule. Uses describe provider practice under the manufacturer's CE marking; no US FDA clearance is claimed here.
- Coolwaves2.45 GHz
- 2.45 GHz microwave — fat-selective energy delivery, sapphire-crystal contact cooling
- Modesthree
- Localized fat · cellulite · laxity — abdomen, thighs, buttocks
- Workflow15–20 min
- 15–20 min per area, no downtime required afterward; courses typically run 3–4 sessions
- Evidence17 studies
- 17 peer-reviewed studies; manufacturer-reported 80%+ energy absorption in subcutaneous fat
Coolwaves® emitter
2.45 GHzMicrowave energy into the fat layer
The applicator delivers microwave energy with the manufacturer reporting 80%+ absorption in adipose tissue and deep heating in the 55–60 °C range.
- Frequency
- 2.45 GHz
- Deep heating
- 55–60 °C in fat layer
- Absorption
- 80%+ of energy in fat
Localized fat · cellulite · laxity
Integrated cooling
to 5 °CProtects the dermis
Adjustable cooling that counteracts heat rising from deeper adipose layers, which is what keeps the procedure tolerable without anesthesia.
- Cooling
- adjustable to 5 °C
Sapphire-crystal contact cooling
Quadrant protocol
15×15 cmRepeatable, staffable delivery
Areas are mapped into 15×15 cm quadrants, each treated in roughly 15–20 minutes, across more than ten body areas — abdomen, flanks, arms, thighs, above knee, buttocks, back.
- Quadrant
- 15×15 cm
- Time
- 15–20 min per quadrant
- Areas
- 10+ mapped body areas
Abdomen · flanks · arms · thighs · above knee · buttocks · back
Course structure
3–4 sessionsHow it books
Protocols run 3–4 sessions spaced 3–4 weeks apart, with no downtime required after a session — which is what makes it a package sale rather than a one-off.
- Sessions
- 3–4
- Interval
- 3–4 weeks
Sold as a course, not a single appointment
What the platform is, line by line
Coolwaves 2.45 GHz microwave. Specifications are provided by the manufacturer. Treatments listed on this page describe how licensed providers use the platform, not cleared indications.
| Specification | Value |
|---|---|
| Energy | Coolwaves® 2.45 GHz microwave — microwave, not radiofrequency |
| Absorption | Manufacturer reports 80%+ of delivered energy absorbed by subcutaneous fat |
| Deep heating | 55–60 °C reported in the fat layer while the energy passes through skin |
| Cooling | Sapphire-crystal contact cooling, adjustable to 5 °C |
| Modes | Localized fat · cellulite · laxity |
| Protocol | 15×15 cm quadrants at roughly 15–20 minutes each, across 10+ mapped body areas |
| Course | 3–4 sessions spaced 3–4 weeks apart, no downtime required afterward |
| Published record | 17 peer-reviewed studies on the underlying technology |
| Power supply | Full-range 110–220 V, so the platform fits most US treatment rooms |
Microwave is a different physics problem than RF
Frequency and absorption are what separate this platform from the radiofrequency body devices it sits beside in the catalog.
- Selective absorption in adipose tissue
- At 2.45 GHz the manufacturer reports more than 80% of delivered energy absorbed by the fat layer, so the energy is deposited where the target is instead of heating everything on the way down.
- Heat from the inside out
- Deep heating in the fat layer is reported at 55–60 °C while the energy passes through skin — the inverse of contact-heating devices that must drive heat downward from the surface.
- Active cooling against rising heat
- An integrated cooling system, adjustable to 5 °C, counteracts heat rising from deeper adipose layers so the dermis is not carried along with the target.
- Quadrant protocol, not freehand
- Treatment is delivered in defined 15×15 cm quadrants at roughly 15–20 minutes per quadrant, with 3–4 sessions spaced 3–4 weeks apart — a schedulable, repeatable protocol you can staff and price.
17 peer-reviewed studies, and one marking that is not a clearance
ONDA has the broadest peer-reviewed literature in this catalog. A representative selection with design stated — read alongside the regulatory row, which is the first thing a US buyer has to settle.
| Source | What it says | What it does not establish |
|---|---|---|
| Regulatory marking | ONDA is CE-marked; no US FDA clearance is claimed here. | A CE mark is a European conformity marking, not a United States clearance, and it authorises no indication here. Confirm the current US regulatory status and permitted marketing language with the manufacturer before you advertise any indication. |
| Zorini et al., 2019–2020 | Animal model, histological. Histological assessment of collagen and adipose remodeling — the tissue-level mechanism work underpinning later clinical studies. | An animal model. It describes tissue-level change, not an appearance outcome in a person. |
| Di Pietro et al., 2019 | 30 women, 2 sessions. Cellulite severity and patient satisfaction assessment. | A small single-arm cohort over two sessions, with satisfaction as one of its endpoints. There is no control arm and we reproduce no effect size. |
| Bionan et al., 2019 | Prospective, n=12, 6 monthly sessions. Circumference and skin tone endpoints. | Twelve patients. A cohort that size shows feasibility, not generalisable effect. |
| Benardo et al., 2022 | Prospective, n=26, 3 sessions, 6-month follow-up. Waist circumference and body contour endpoints. | Prospective but uncontrolled. Circumference is a proxy measure and the follow-up stops at six months. |
| Salti et al., 2023 | n=34, 12-month follow-up. Cellulite grade and skin tone durability at one year. | Durability in one cohort of 34, graded rather than measured. It is not a comparison with any other treatment. |
| Ruiz-Rosas et al., 2023 | n=55, Latin American cohort. Waistline and body contour endpoints in a non-European population. | One population, one set of anthropometric endpoints. It broadens who has been studied, not what has been proven. |
| Palmitieri et al., 2023 | Overweight adults, n=35, 6 sessions. BMI and waist anthropometric endpoints. | BMI and waist are body measurements, not a device-attributable result; the study does not separate the platform from anything else the participants did. |
| Hoffman et al., 2024 | Expert review, 27 dermatologists. Consensus review of microwave technology for cellulite, laxity and localized adiposity. | Consensus is expert opinion about a technology class. It is not a clinical endpoint and it confers no regulatory status. |
These are studies of the underlying ONDA Coolwaves® microwave technology, published across roughly 400+ patients. They are listed as a bibliography with study design so you can read them yourself — we do not reproduce effect sizes here and nothing on this page claims a result for any patient. ONDA is CE-marked; no US FDA clearance is claimed. Confirm the current US regulatory status and permitted marketing language with the manufacturer before you advertise any indication. What it does give you is a bibliography with study design attached, which is the honest form of a body-contouring evidence claim and the only form a clinical reviewer can actually work with.
What it costs to buy, and what it costs to run
A laser that sits idle loses money. The support around the device is what turns capital into revenue — handled by the same team that sources your pharmacy and biologics.
I sell the install and the training as hard as the platform. An idle device is the only bad outcome here.
- Price and financing
- Platforms like this do not carry a sticker price. Configuration, applicators, training and term all move the number, so the question that actually matters is the monthly. Most device financing here lands near $2,500 per month, pending configuration, credit approval, rates and terms. Tell us which treatments you want on the menu and we work the number back from the revenue they carry. Weighing the options? Read Buy vs. lease your first laser.
- Launch programs
- The manufacturer also runs launch programs for early providers that can include clinical training, marketing kits and referral placement — we'll tell you what is actually available at the time you quote.
- Installation and site prep
- Voltage, footprint, and installation handled — full-range 110–220V platforms fit most rooms. Site prep, voltage and footprint checks are handled before delivery.
- Clinical training
- Hands-on protocols and KOL-backed education so staff are treating confidently from day one.
- Warranty and service
- Warranty and service terms are set by the manufacturer and vary by platform — the current terms are included in every quote. Eventide remains your single point of contact after installation.
- Who makes it, who sells it
- ONDA · bodyESTIQ is manufactured by DEKA. Eventide Aesthetics & Wellness is a United States distributor supplying it to licensed providers and practice owners — we handle the quote, the financing, the install and the training, and we stay your point of contact after the sale.
- Who it is sold to
- This is a business-to-business page. ONDA · bodyESTIQ is sold to licensed medical providers and the practices they operate, not to consumers, and nothing here is directed at patients. We support clinics in all 50 US states.
What buyers ask about the ONDA · bodyESTIQ
Is financing available for the ONDA · bodyESTIQ?
Yes. Leasing and financing are structured to your practice so the platform pays for itself as it books. Every quote includes transparent pricing, financing terms, and an ROI view. If you are weighing purchase against a lease, start with our guide, Buy vs. lease your first laser.
Are training and installation included?
Yes. Site prep, voltage, and installation are handled — full-range 110–220V platforms fit most rooms — and clinical onboarding with hands-on protocols and KOL-backed education is included, so staff are treating confidently from day one. One point of contact covers quote, install, and training.
What about warranty and support?
Warranty and service terms are set by the manufacturer and vary by platform — the current terms are included in every quote. Eventide remains your single point of contact after installation, coordinating service and support with the same team that handles your other supply lines.
What is ONDA's regulatory status?
ONDA is CE-marked; no US FDA clearance is claimed here. Treatments listed on this page describe how licensed providers use the platform, not cleared indications.
How much does an ONDA bodyESTIQ cost?
Pricing depends on configuration and program. The manufacturer also runs launch programs for early providers that can include clinical training, marketing kits and referral placement — we'll tell you what is actually available at the time you quote. Most practices ask for the monthly rather than the sticker, and device financing here typically lands near $2,500 per month, pending configuration, credit approval, rates and terms.
How is ONDA different from radiofrequency body devices?
Frequency and absorption. ONDA is 2.45 GHz microwave rather than RF, and the manufacturer reports 80%+ of that energy absorbed by adipose tissue with deep heating at 55–60 °C — energy deposited in the fat layer rather than driven down from the skin surface. Practically, that is why the protocol is quadrant-based and short per area.
How long does an ONDA treatment take and how many sessions?
Roughly 15–20 minutes per 15×15 cm quadrant, with courses typically structured as 3–4 sessions spaced 3–4 weeks apart, and no downtime required afterward.
Who distributes ONDA · bodyESTIQ in the United States?
Eventide Aesthetics & Wellness distributes ONDA · bodyESTIQ to licensed providers and practice owners across all 50 US states. ONDA · bodyESTIQ is manufactured by DEKA; Eventide is a distributor, not the manufacturer, and handles the quote, financing, installation, clinical training and ongoing support.
How do I buy ONDA · bodyESTIQ for my clinic?
Start with a 15–20 minute call. We scope your space, budget and treatment menu, then send pricing, financing terms, spec sheets and an ROI view before you commit. After you order, site prep and installation are handled and your staff get hands-on clinical onboarding. Call 813-544-7131 or email justin@eventideaw.com.
Specifications and regulatory status reviewed 24 July 2026 by Justin Messner, Co-Founder, Eventide Aesthetics & Wellness.
Important information for providers. ONDA is CE-marked; no US FDA clearance is claimed here. Treatments listed describe how licensed providers use the platform, not cleared indications. Eventide Aesthetics & Wellness is a distributor, not a manufacturer. Product specifications are provided by the manufacturer. No treatment outcome is claimed or guaranteed. For licensed medical providers.